MED19 and neoplasm: The expression level of Med19, particularly localized in the nucleus and cytoplasm of tumour cells, correlates with advanced stage (P = 0.003) and high grade (P = 0.001), but did not show a significant association with gender (P = 0.738), tumour number (P = 0.071) or recurrence (P = 0.101).